Department of Medicine, University of Otago Christchurch, PO Box 4345, Christchurch, 8140, New Zealand.
Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101719. doi: 10.1016/j.berh.2021.101719. Epub 2021 Oct 28.
The purpose of gout treatment is to alleviate symptoms of flares, prevent flares from recurring by lowering serum urate, and minimize structural joint damage and functional impairment. In recent years, several new medications to treat gout have been developed, and novel agents continue to be investigated, in addition to several long-established treatments. Although a number of effective therapies are available, optimal management and outcomes are frequently not achieved due to physician under prescribing of urate-lowering therapy (ULT) and poor adherence with therapy when it is prescribed. This article reviews recent developments in the management of gout with reference to recently published clinical guidelines, outlines some important questions regarding the safety and efficacy of particular agents, and remaining gaps in our knowledge about the most effective strategies for using currently available treatments.
痛风治疗的目的是缓解急性发作症状,通过降低血清尿酸盐来预防急性发作复发,并最大程度地减少结构关节损伤和功能障碍。近年来,已经开发出几种治疗痛风的新药物,除了几种长期确立的治疗方法外,还在不断研究新的药物。尽管有许多有效的治疗方法,但由于医生开低尿酸降低治疗(ULT)药物和在开处方时对治疗的依从性差,往往无法实现最佳的管理和治疗效果。本文参考最近发表的临床指南,综述了痛风管理方面的最新进展,概述了一些关于特定药物安全性和有效性的重要问题,以及在使用现有治疗方法方面最有效的策略方面的知识空白。